08:14 AM EST, 11/07/2024 (MT Newswires) -- Viatris ( VTRS ) reported Q3 adjusted earnings Thursday of $0.75 per diluted share, compared with $0.79 a year earlier.

Analysts surveyed by Capital IQ expected $0.68.

Revenue for the quarter ended Sept. 30 was $3.74 billion, compared with $3.93 billion a year earlier. Analysts surveyed by Capital IQ expected $3.71 billion.

For full-year 2024, the pharmaceutical company said it expects adjusted EPS of $2.56 to $2.71, down from previous guidance of $2.58 to $2.73. It also maintained its revenue guidance of $14.6 billion to $15.1 billion.

Analysts surveyed by Capital IQ expect full-year adjusted EPS of $2.68 on revenue of $14.83 billion.

Shares of Viatris ( VTRS ) were gaining over 1% in recent premarket activity.

Price: 11.79, Change: +0.18, Percent Change: +1.55